JPS59500597A - 形質転換させた微生物からヒトＩＦＮ−βを回収する方法 - Google Patents

形質転換させた微生物からヒトＩＦＮ−βを回収する方法

Info

Publication number
JPS59500597A
JPS59500597A JP58501024A JP50102483A JPS59500597A JP S59500597 A JPS59500597 A JP S59500597A JP 58501024 A JP58501024 A JP 58501024A JP 50102483 A JP50102483 A JP 50102483A JP S59500597 A JPS59500597 A JP S59500597A
Authority
JP
Japan
Prior art keywords
butanol
phase
extractant
ifn
aqueous medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58501024A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0449999B2 (enExample
Inventor
コンラツド・マイケル・ダブリユ−
リン・レオ・エス
Original Assignee
シェーリング　アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シェーリング　アーゲー filed Critical シェーリング　アーゲー
Publication of JPS59500597A publication Critical patent/JPS59500597A/ja
Publication of JPH0449999B2 publication Critical patent/JPH0449999B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58501024A 1982-03-01 1983-02-10 形質転換させた微生物からヒトＩＦＮ−βを回収する方法 Granted JPS59500597A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/353,360 US4450103A (en) 1982-03-01 1982-03-01 Process for recovering human IFN-β from a transformed microorganism
US353360 1982-03-01

Publications (2)

Publication Number Publication Date
JPS59500597A true JPS59500597A (ja) 1984-04-12
JPH0449999B2 JPH0449999B2 (enExample) 1992-08-13

Family

ID=23388775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58501024A Granted JPS59500597A (ja) 1982-03-01 1983-02-10 形質転換させた微生物からヒトＩＦＮ−βを回収する方法

Country Status (8)

Country Link
US (1) US4450103A (enExample)
EP (1) EP0102989B1 (enExample)
JP (1) JPS59500597A (enExample)
AU (1) AU549721B2 (enExample)
CA (1) CA1187013A (enExample)
DE (1) DE3363647D1 (enExample)
IT (1) IT1164626B (enExample)
WO (1) WO1983003103A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061649A1 (en) * 1998-05-26 1999-12-02 Hsp Research Institute, Inc. Method for recovering soluble protein

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
DE3421302A1 (de) * 1984-06-08 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US5248769A (en) * 1985-06-26 1993-09-28 Cetus Oncology Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
EP0511964B1 (fr) * 1990-11-23 1997-10-15 Roussel Uclaf PROCEDE DE PREPARATION D'UNE PROTEINE CHOISIE PARMI LES CYTOKINES, COMPORTANT AU MOINS UN PONT DISULFURE INTRAMOLECULAIRE PAR OXYDATION, A UN pH INFERIEUR A 5,0, DE LA PROTEINE RECOMBINANTE REDUITE CORRESPONDANTE
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
CA2212446C (en) * 1995-12-21 2010-09-21 Genzyme Corporation Method for lysing cells
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
AU1275899A (en) 1997-10-24 1999-05-17 Megabios Corporation Methods for preparing polynucleotide transfection complexes
JP2003530838A (ja) * 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2446739A1 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
AU2002364587A1 (en) * 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
ES2425738T3 (es) * 2001-12-21 2013-10-17 Human Genome Sciences, Inc. Proteínas de fusión de la albúmina
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
CA2498518A1 (en) 2002-09-13 2004-03-25 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
JP2007526317A (ja) * 2004-03-01 2007-09-13 エンゾン ファーマスーティカルズ インコーポレイテッド インターフェロン−ベータ・ポリマー結合体
US7628920B2 (en) * 2004-04-07 2009-12-08 Waters Technologies Corporation Compositions and methods for separating enantiomers
DE102004047189A1 (de) 2004-09-29 2006-04-06 Robert Bosch Gmbh Sensor zur Ortung metallischer Objekte sowie Verfahren zur Auswertung von Messsignalen eines solchen Sensors
WO2008051178A2 (en) * 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US8188224B2 (en) 2005-04-11 2012-05-29 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
CA2673398A1 (en) * 2006-12-19 2008-07-03 Merrimack Pharmaceuticals, Inc. Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
EP2207890A4 (en) * 2007-10-05 2010-12-15 Barofold Inc HIGH PRESSURE PROCESSING OF AGGREGATED INTERFERONS
EA022201B1 (ru) 2008-04-11 2015-11-30 Мерримак Фармасьютикалз, Инк. Агент, способный связываться с опухолевой клеткой, содержащий линкер на основе hsa, и его применение
AU2009240738B2 (en) 2008-04-21 2014-09-11 Tissue Regeneration Therapeutics, Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
JP5677972B2 (ja) 2008-11-18 2015-02-25 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
WO2010142017A1 (en) * 2009-06-09 2010-12-16 Defyrus, Inc . Administration of interferon for prophylaxis against or treatment of pathogenic infection
EP4635567A3 (en) 2009-06-25 2025-12-03 Horizon Therapeutics USA, Inc. Methods and kits for preventing infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US20150202287A1 (en) 2012-08-30 2015-07-23 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-erbb3 agents
CN110234340A (zh) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
US4315852A (en) * 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061649A1 (en) * 1998-05-26 1999-12-02 Hsp Research Institute, Inc. Method for recovering soluble protein
US6861505B1 (en) 1998-05-26 2005-03-01 Hsp Research Institute, Inc. Method for recovering soluble protein

Also Published As

Publication number Publication date
DE3363647D1 (en) 1986-07-03
AU1331783A (en) 1983-10-18
US4450103A (en) 1984-05-22
CA1187013A (en) 1985-05-14
EP0102989B1 (en) 1986-05-28
WO1983003103A1 (en) 1983-09-15
EP0102989A1 (en) 1984-03-21
JPH0449999B2 (enExample) 1992-08-13
IT1164626B (it) 1987-04-15
AU549721B2 (en) 1986-02-06
IT8347779A0 (it) 1983-02-24

Similar Documents

Publication Publication Date Title
JPS59500597A (ja) 形質転換させた微生物からヒトＩＦＮ−βを回収する方法
US4462940A (en) Process for the recovery of human β-interferon-like polypeptides
US4992271A (en) Formulation for lipophilic IL-2 proteins
US5814485A (en) Production of interferon-β (IFN-β) in E. coli
CA2222456A1 (en) Vaccines against hepatitis c
GB1587782A (en) Process for recovering purified alubumin from blood plasma
US5702699A (en) Process for the recovery of lipophilic proteins
CA1291594C (en) Agent for the removal of nucleic acids and/or endotoxin and method for the removal thereof
JPS63169995A (ja) β−インターフェロンの回収及び精製方法
JPS6265696A (ja) 有機酸によりタンパク質を抽出する方法
DE3855986T2 (de) Prozess zur gewinnung von gereinigtem, oxidiertem, renaturiertem, rekombinantem interleukin-2 aus mikroorganismen
US4364863A (en) Extraction of interferon from bacteria
JPH0822879B2 (ja) 冷沈澱により抗血友病因子を製造し且つ得られる抗血友病因子製品の溶解度を改善するための方法
JPS63258492A (ja) 生物学的に活性な単量体成長ホルモンの回収精製方法
US6821752B2 (en) Methods and compositions for extracting proteins from cells
EP0163573B1 (en) Site-specific proteolysis by renin
JPH04505706A (ja) 組み換えタンパク質の回収法
EP0180012A1 (de) Immunogene Polypeptidsequenz des Hepatitis B-Virus
JPS62503143A (ja) 形質転換した微生物からのソマトトロピンの精製
Lyttleton A simple method of isolating ribosomes from Tetrahymena pyriformis
RU2123010C1 (ru) Способ получения рекомбинантного интерферона-альфа-2 из нерастворимых тел включения
WO1993003134A1 (en) Process for isolating and purifying recombinant interleukin-7
CN121554547A (zh) 牛病毒性腹泻病毒ctl表位多肽及其应用
WO1997048808A1 (en) Bacterial production of interferon-beta using low levels of sodium and potassium ions
IL120009A (en) Method for production of interferon - ?? polypeptide in a host cell